Yigui Chen

机构：Fujian Medical University, Ministry of Natural Resources, China Geological Survey, Qingdao Institute of Marine Geology, Fujian Provincial Cancer Hospital · ORCID：0000-0001-6488-5010

发表论文 41 篇 · 总被引 312 次 · h-index 9

代表论文

• Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703) (2021 · The Oncologist · 被引 64)
• Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial (2021 · Journal of the National Comprehensive Cancer Network · 被引 26)
• Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer (2021 · Frontiers in Genetics · 被引 18)
• A phase I/II study of ASKB589 (anti-claudin 18.2 [CLDN18.2] monoclonal antibody) in patients with solid tumors. (2023 · Journal of Clinical Oncology · 被引 13)
• First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 8)
• Prognostic values of regulatory T cells (Tregs) and Treg-related genes in gastric cancer (2023 · Central European Journal of Immunology · 被引 8)